中文|English
  • Projects in Clinical Studies
  • Projects in Pr-clinical Studies
    • Home > Research projects >Projects in Clinical Studies

    Projects in Clinical Studies

    The Introduction of Hemay102
    Hemay102, a proprietary new chemical entity currently under investigation, is a .....
    More>>
    The Introduction of Hemay022
    Hemay022, a tyrosine kinase irreversible inhibitor, is a proprietary new chemica.....
    More>>
    The Introduction of Hemay020
    Hemay020, a tyrosince kinase irreversible inhibitor, is a proprietary new chemic.....
    More>>
    The Introduction of Hemay007
    Hemay007, a proprietary new chemical entity of the immunomodulatory agent, is a .....
    More>>
    The Introduction of Hemay005
    Hemay005, a PDE4 inhibitor, is a proprietary new chemical entity being developed.....
    More>>

    About us

    Research projects

    Careers

    All rights reserved (2017), tianjin ICP for 05010040